e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Pre-clinical models of airways disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Essential role for ATP in the pathogenesis of COPD and emphysema
S. Cicko, M. Lommatzsch, M. Lucattelli, T. Müller, G. De Cunto, G. Lungarella, J. C. Virchow, M. Idzko (Freiburg, Rostock, Germany; Siena, Italy)
Source:
Annual Congress 2010 - Pre-clinical models of airways disease
Session:
Pre-clinical models of airways disease
Session type:
Oral Presentation
Number:
5152
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Cicko, M. Lommatzsch, M. Lucattelli, T. Müller, G. De Cunto, G. Lungarella, J. C. Virchow, M. Idzko (Freiburg, Rostock, Germany; Siena, Italy). Essential role for ATP in the pathogenesis of COPD and emphysema. Eur Respir J 2010; 36: Suppl. 54, 5152
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
PP108 – Role of TRIM-16-mediated lysophagy in COPD pathogenesis
Source: ERS Lung Science Conference 2021
Year: 2021
Phospholipid homeostasis and IPF pathogenesis
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010
Viral persistence in the pathogenesis of COPD
Source: Annual Congress 2010 - Treatment of bronchial infection: beyond the exacerbations
Year: 2010
The role of small airways in asthma pathophysiology
Source: Annual Congress 2011 - Small airways: important in COPD and severe asthma
Year: 2011
Clinically important major phenotypes of COPD
Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD
Year: 2011
Role of obesity in asthma and COPD
Source: Annual Congress 2011 - PG5 Asthma versus COPD: similarities and differences
Year: 2011
Essential role of sirtuins in the pathogenesis of allergic airway inflammation
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Dysregulated ECM stability: A pathomechanism in chronic obstructive pulmonary disease?
Source: Annual Congress 2010 - New mechanisms in chronic lung diseases
Year: 2010
Role of necroptosis in the pathogenesis of COPD
Source: International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease
Year: 2019
Adenosine signalling in asthma and COPD
Source: Annual Congress 2011 - Adenosine and purigenic signalling in inflammatory lung disease
Year: 2011
The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Biomarkers in asthma and COPD
Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine
Year: 2011
Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma
Source: Eur Respir J, 55 (4) 1901340; 10.1183/13993003.01340-2019
Year: 2020
Disturbed hypoxic-angiogenic signalling mediating muscle cachexia in COPD
Source: Annual Congress 2010 - New mechanisms in chronic lung diseases
Year: 2010
The role of ATP and purinergic-receptor- signalling in the pathogenesis of ALI/ARDS
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
Clinically important phenotypes of COPD
Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept